Sepiapterin reductase expression is increased in Parkinson's disease brain tissue
- 8 January 2007
- journal article
- Published by Elsevier in Brain Research
- Vol. 1139, 42-47
- https://doi.org/10.1016/j.brainres.2007.01.001
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- A Murine Model for Human Sepiapterin-Reductase DeficiencyAmerican Journal of Human Genetics, 2006
- The sepiapterin reductase gene region reveals association in the PARK3 locus: analysis of familial and sporadic Parkinson's disease in European populationsJournal of Medical Genetics, 2005
- Loss of striatal dopaminergic fibers after intraventricular injection of tetrahydrobiopterin in rat brainNeuroscience Letters, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genesEuropean Journal of Human Genetics, 2001
- Accuracy of Haplotype Frequency Estimation for Biallelic Loci, via the Expectation-Maximization Algorithm for Unphased Diploid Genotype DataAmerican Journal of Human Genetics, 2000
- Genomic Organization and Chromosomal Localization of the Human Sepiapterin Reductase GeneBiochemical and Biophysical Research Communications, 1998
- Cloning and sequencing of cDNA encoding human sepiapterin reductase: An enzyme involved in tetrahydrobiopterin biosynthesisBiochemical and Biophysical Research Communications, 1991
- Human carbonyl and aldose reductases: New catalytic functions in tetrahydrobiopterin biosynthesisBiochemical and Biophysical Research Communications, 1991
- Sepiapterin reductase exhibits a NADPH-dependent dicarbonyl reductase activityBiochemical and Biophysical Research Communications, 1984